Study Reveals Many Cancer Patients are Killed by Chemotherapy, Not Cancer

In 2018, a headline for an article in The Economist succinctly captured the paradox that is the global cancer industry: “Cancer is a Curse, but Also a Growth Market for Investors.” Cancer’s definitely a curse, that’s for sure, but cancer drugs, with chemotherapy drugs taking up the lion’s share, are on pace to become a $200 […]